UBC Medical Indonesia Tbk. vs Super Bank Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Super Bank Indonesia Tbk. trades at Rp590 (market cap 19.63T, 9.84M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 34× UBC Medical Indonesia Tbk.'s market cap, and Super Bank Indonesia Tbk. is more actively traded (9.84M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SUPA | |
|---|---|---|
Market Cap | 576.7B | 19.63T |
Volume | 3.48M | 9.84M |
Lot | 34.82K | 98.38K |
Turnover | 522.79M | 5.78B |
Average Price | 150.13 | 587.51 |
Value | 522.79M | 5.78B |
Indicative Equilibrium Price | 148 | 590 |
Indicative Equilibrium Volume | 350 | 803 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →